Core Laboratories Inc.
CLB
$13.36
$0.181.33%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -789.00K | 4.95M | 14.24M | 10.64M | -154.00K |
| Total Depreciation and Amortization | 3.76M | 3.67M | 3.59M | 3.67M | 3.72M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.77M | 8.47M | -4.44M | -1.72M | 5.61M |
| Change in Net Operating Assets | -778.00K | -9.14M | -4.89M | 1.34M | -2.51M |
| Cash from Operations | 3.97M | 7.95M | 8.50M | 13.92M | 6.66M |
| Capital Expenditure | -4.89M | -3.65M | -3.03M | -4.33M | -3.58M |
| Sale of Property, Plant, and Equipment | 1.49M | 668.00K | 152.00K | 966.00K | 1.23M |
| Cash Acquisitions | -- | -620.00K | 0.00 | -617.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.00K | -148.00K | 5.27M | 2.34M | 3.12M |
| Cash from Investing | -3.39M | -3.75M | 2.39M | -1.64M | 772.00K |
| Total Debt Issued | 66.00M | 12.00M | 11.00M | 12.00M | 13.00M |
| Total Debt Repaid | -62.00M | -16.00M | -20.00M | -12.00M | -15.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -4.00M | -2.66M | -5.01M | -2.74M | -2.02M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -460.00K | -466.00K | -465.00K | -469.00K | -469.00K |
| Other Financing Activities | -- | 1.00K | -1.98M | 10.00K | 9.00K |
| Cash from Financing | -457.00K | -7.12M | -16.45M | -3.20M | -4.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.00K | -2.93M | -5.56M | 9.08M | 2.95M |